Webinar

Join us for an exclusive webinar exploring practical strategies to improve therapeutic antibody manufacturing through integrated upstream and downstream process solutions. As therapeutic antibody titers continue to rise, manufacturers face...

As the December 1, 2026 release of the revised USP <87>, Biological Reactivity Tests, In Vitro, approaches, pharmaceutical and medical device manufacturers should begin evaluating how these changes may impact...